South San Francisco, CA · Founded 2019 · Privately Held (backing)
Operator of an integrated development and manufacturing organization intended for accelerating patients' access to life-saving cell therapies. Cellares is based in South San Francisco, CA and was founded in 2019. It is valued at about $675 million as of Oct 2026, set by institutional fund marks. It has raised $612 million across 1 recorded round; the latest was an $82 million later-stage round in Apr 2021.
PMV mark · valuation
$675.0M
Oct 2026
Priced at
its later-stage round
Aug 2023
Total raised
$612.0M
Last round
Later Stage VC
Apr 2021
No prints on record
No secondary trades in Cellares shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Cellares stock.
